Earnings Call · Q3 FY2023·2023-11-02

Q3 23EPS +4.49%·Rev n/aQ2 23EPS +41.43%·Rev n/aQ1 23EPS +10.53%·Rev n/aQ4 22EPS -47.83%·Rev n/a⚠ consensus missing

IONIS PHARMACEUTICALS INC IONS

Wade Walke — Senior Vice President of Investor Relations

Brett Monia — Chief Executive Officer

Onaiza Cadoret — Executive, likely Head of Commercial or similar

Richard Geary — Executive, likely Chief Medical Officer or similar

Beth Hougen — Executive, likely Chief Financial Officer or similar

−3.4%1d on move date−5.3% vs SPY3d+2.3%5d+4.0%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more IONS calls or request research access.

More IONS calls Browse calls Request research access